Moderna, Inc. MRNA
Set alert
At close · Nov 2
After hours · Nov 2, 6:50 PM ET
- YTD
- +648.83%
- 1 year
- +713.07%
- Open
- 224.16
- Prev close
- 221.72
- Mkt cap
- 88.16B
- Vol
- 8.41M
- Avg vol
- 21.30M
- EPS
- -7.98
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 217.66
- High
- 230.52
- Forward P/E
- -48.16
- Beta
- 1.17
- Short ratio
- 1.86
- Inst. own
- 80.49%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 6, 2026
- 50-d avg
- 182.49
- 200-d avg
- 86.58
- 1y target
- 138.37
5D chart
Events in this range
- Oct 27, 2026Downgrade: William Blair · Outperform → Market Perform
Signals (149)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 4:00 PM | 2 hours ago |
| SMA: Bullish | Nov 2, 3:55 PM | 2 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 3:15 PM | 3 hours ago |
| SMA: Bearish | Nov 2, 3:10 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 3:05 PM | 3 hours ago |
| SMA: Bearish | Nov 2, 3:00 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 3 hours ago |
| SMA: Bearish | Nov 2, 1:50 PM | 5 hours ago |
| SMA: Bullish | Nov 2, 1:45 PM | 5 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 5 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 5 hours ago |
| MACD: Sell Signal | Nov 2, 1:40 PM | 5 hours ago |
| MACD: Buy Signal | Nov 2, 12:50 PM | 6 hours ago |
| SMA: Bullish | Nov 2, 12:45 PM | 6 hours ago |
| SMA: Bearish | Nov 2, 12:40 PM | 6 hours ago |
| SMA: Bullish | Nov 2, 12:35 PM | 6 hours ago |
| SMA: Bullish | Nov 2, 12:35 PM | 6 hours ago |
| SMA: Bearish | Nov 2, 12:25 PM | 6 hours ago |
| MACD: Sell Signal | Nov 2, 12:25 PM | 6 hours ago |
| SMA: Bearish | Nov 2, 12:20 PM | 6 hours ago |
| MACD: Buy Signal | Nov 2, 11:45 AM | 7 hours ago |
| SMA: Bullish | Nov 2, 11:30 AM | 7 hours ago |
| SMA: Bullish | Nov 2, 11:30 AM | 7 hours ago |
| SMA: Bearish | Nov 2, 11:10 AM | 7 hours ago |
| SMA: Bullish | Nov 2, 11:00 AM | 7 hours ago |
| SMA: Bearish | Nov 2, 10:55 AM | 7 hours ago |
| SMA: Bearish | Nov 2, 10:40 AM | 8 hours ago |
| MACD: Sell Signal | Nov 2, 10:40 AM | 8 hours ago |
| SMA: Bullish | Nov 2, 10:20 AM | 8 hours ago |
| SMA: Bearish | Nov 2, 10:10 AM | 8 hours ago |
| SMA: Bullish | Nov 2, 9:45 AM | 9 hours ago |
| SMA: Bearish | Nov 2, 9:40 AM | 9 hours ago |
| RSI: Overbought | Nov 2, 9:30 AM | 9 hours ago |
| SMA: Bullish | Oct 30, 3:45 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:35 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:25 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:15 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:00 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:55 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:40 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 1:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:35 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 1:20 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:15 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:35 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:10 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 11:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 11:35 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:30 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:50 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:35 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:35 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:05 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:00 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 10:00 AM | 3 days ago |
| SMA: Bullish | Oct 30, 9:55 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:50 AM | 3 days ago |
| RSI: Overbought | Oct 29, 3:55 PM | 4 days ago |
| RSI: Overbought | Oct 29, 3:45 PM | 4 days ago |
| SMA: Bullish | Oct 29, 3:05 PM | 4 days ago |
| SMA: Bearish | Oct 29, 3:00 PM | 4 days ago |
| SMA: Bullish | Oct 29, 2:50 PM | 4 days ago |
| SMA: Bullish | Oct 29, 2:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 2:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 2:25 PM | 4 days ago |
| SMA: Bearish | Oct 29, 2:15 PM | 4 days ago |
| SMA: Bullish | Oct 29, 2:05 PM | 4 days ago |
| SMA: Bearish | Oct 29, 1:40 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 1:25 PM | 4 days ago |
| SMA: Bullish | Oct 29, 1:05 PM | 4 days ago |
| SMA: Bearish | Oct 29, 11:55 AM | 4 days ago |
| SMA: Bearish | Oct 29, 11:55 AM | 4 days ago |
| SMA: Bullish | Oct 29, 11:30 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 10:50 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:20 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 4 days ago |
| RSI: Overbought | Oct 29, 9:50 AM | 4 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 4 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 5 days ago |
| SMA: Bearish | Oct 28, 3:45 PM | 5 days ago |
| SMA: Bearish | Oct 28, 3:45 PM | 5 days ago |
| SMA: Bullish | Oct 28, 3:40 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 3:40 PM | 5 days ago |
| SMA: Bearish | Oct 28, 3:35 PM | 5 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 5 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 3:00 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:55 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:40 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 2:40 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:35 PM | 5 days ago |
| SMA: Bearish | Oct 28, 1:45 PM | 5 days ago |
| SMA: Bearish | Oct 28, 1:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 1:45 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 1:40 PM | 5 days ago |
| SMA: Bullish | Oct 28, 1:30 PM | 5 days ago |
| SMA: Bullish | Oct 28, 1:25 PM | 5 days ago |
| SMA: Bearish | Oct 28, 1:10 PM | 5 days ago |
| SMA: Bearish | Oct 28, 12:55 PM | 5 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 5 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 5 days ago |
| SMA: Bearish | Oct 28, 12:35 PM | 5 days ago |
| SMA: Bearish | Oct 28, 12:35 PM | 5 days ago |
| SMA: Bullish | Oct 28, 12:30 PM | 5 days ago |
| SMA: Bullish | Oct 28, 12:30 PM | 5 days ago |
| SMA: Bearish | Oct 28, 12:10 PM | 5 days ago |
| SMA: Bearish | Oct 28, 12:05 PM | 5 days ago |
| SMA: Bullish | Oct 28, 11:50 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:45 AM | 5 days ago |
| SMA: Bullish | Oct 28, 11:20 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:10 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:35 AM | 5 days ago |
| RSI: Overbought | Oct 28, 10:35 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:25 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 10:25 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:20 AM | 5 days ago |
| RSI: Overbought | Oct 28, 10:20 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:15 AM | 5 days ago |
| MACD: Buy Signal | Oct 28, 9:40 AM | 5 days ago |
| RSI: Overbought | Oct 28, 9:35 AM | 5 days ago |
| SMA: Bullish | Oct 27, 3:55 PM | 6 days ago |
| SMA: Bearish | Oct 27, 3:50 PM | 6 days ago |
| MACD: Sell Signal | Oct 27, 3:50 PM | 6 days ago |
| RSI: Overbought | Oct 27, 3:30 PM | 6 days ago |
| MACD: Buy Signal | Oct 27, 2:40 PM | 6 days ago |
| RSI: Overbought | Oct 27, 2:40 PM | 6 days ago |
| SMA: Bullish | Oct 27, 2:05 PM | 6 days ago |
| SMA: Bearish | Oct 27, 2:00 PM | 6 days ago |
| SMA: Bullish | Oct 27, 1:10 PM | 6 days ago |
| SMA: Bearish | Oct 27, 1:05 PM | 6 days ago |
| SMA: Bullish | Oct 27, 12:35 PM | 6 days ago |
| SMA: Bearish | Oct 27, 12:20 PM | 6 days ago |
| SMA: Bullish | Oct 27, 11:25 AM | 6 days ago |
| SMA: Bearish | Oct 27, 11:05 AM | 6 days ago |
News
5 hours ago zacks.com
Buy Moderna Stock Before Q3 Earnings? Here's What to Know
Moderna MRNA is scheduled to report third-quarter 2026 earnings on Nov. 6, before the opening bell. The Zacks Consensus Estimate for sales is pinned at $888.8 million, while that for earnings is…
14 hours ago fool.com
Stock Split Watch: Is Moderna Next?
A stock split lowers the price of a stock, opening up the investing opportunity to a broader range of investors. Investors, excited about Moderna's personalized cancer vaccine candidate, have flocked…
1 day ago benzinga.com
Tempus AI Earnings Ahead: Is TEM Set Up To Pop or Drop?
Tempus AI, a company that Cathie Wood has invested in, will publish its financial results this week as its volatility continues.
1 day ago youtube.com
Moderna, Merck eye FDA approval for promising cancer vaccine
Moderna co-founder and board chairman Noubar Afeyan discusses the biotech company's melanoma vaccine trial results and efforts to secure FDA approval on 'The Claman Countdown.' #fox #foxbusiness…
1 day ago barrons.com
Jobs, Midterm Elections, Apple, Palantir, McDonald's, Moderna, and More to Watch This Week
In another busy earnings week, AMD, Estée Lauder, Qualcomm, Pfizer, and many more will report results. We'll see three readings on jobs this week, as well as data on the manufacturing and services…
1 day ago benzinga.com
Earnings Volatility Watch: 10 Stocks Are Set to Swing More Than 10% This Week
Ten stocks carry implied earnings moves above 10% next week, led by Moderna and AppLovin. Five are tech names hit in Friday's chip rout.
3 days ago benzinga.com
Merck One of Top Large-Cap Biopharma Picks-Analyst
Merck beats Q3 estimates on oncology strength and raised guidance, while Guggenheim eyes pipeline progress ahead of Keytruda patent loss.
3 days ago 247wallst.com
Regeneron Surges 12% as Sanofi Dupixent Windfall and Eylea HD Power Earnings Beat; Moderna Slides 2%, Merck Edges Higher, Pfizer Ticks Up
A strong third quarter has made Regeneron Pharmaceuticals (NASDAQ:REGN | REGN Price Prediction) a standout healthcare gainer on a day when tech stocks are selling off. In morning trading, Regeneron…
3 days ago zacks.com
Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline
Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 days ago zacks.com
GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth?
GSK's Specialty Medicines growth, deep pipeline and dividend offer a compelling case against MRNA's oncology potential and premium valuation.
4 days ago zacks.com
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Moderna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
4 days ago fool.com
Will Moderna Soar on Nov. 6?
Investors are excited about Moderna's personalized cancer vaccine candidate, which recently delivered positive clinical trial data. The stock surged after data was released in August but has given up…
5 days ago wsj.com
Moderna's CEO told The Wall Street Journal that his cancer vaccine's data will get better with time, and that no one can easily copy the company's work
Stéphane Bancel defended his melanoma data and argued that rivals can't easily copy the technology.
5 days ago 247wallst.com
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
Shrugging off a valuation downgrade, Moderna (NASDAQ:MRNA | MRNA Price Prediction) is climbing as investors weigh strong cancer vaccine data against a share price that already reflects big…
5 days ago fool.com
Axsome Therapeutics vs. Moderna: Consistent Revenue Growth or Sharp Volatility
Axsome Therapeutics (AXSM -1.29%) primarily discovers, develops, and exclusively commercializes innovative medical treatments targeting numerous central nervous system disorders domestically.
6 days ago marketbeat.com
Merck and Moderna's Cancer Vaccine Worked—Who Gets Paid?
Merck & Co. NYSE: MRK and Moderna NASDAQ: MRNA just cleared a bar no cancer vaccine had cleared before. Their personalized melanoma vaccine succeeded in a Phase 3 trial.
6 days ago benzinga.com
This M&T Bank Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
Analysts downgraded M&T Bank, Bank of Hawaii, HubSpot, Abbott and Moderna; Bank of Hawaii cut its target, while HubSpot’s rose.
6 days ago benzinga.com
William Blair Takes a Shot at Moderna Stock: Downgrade to Market Perform After a 545% Run
Moderna Inc. (NASDAQ:MRNA) shares are trading lower Tuesday after William Blair downgraded the stock to Market Perform from Outperform on Monday, citing valuation concerns.
6 days ago benzinga.com
William Blair Takes a Shot at Moderna Stock: Downgrade to Market Perform After a 545% Run
Moderna shares are trading lower Tuesday after William Blair downgraded the stock to Market Perform on Monday, citing valuation concerns.
6 days ago barrons.com
Moderna Has Its Doubters. CEO Bancel Plans to Answer With a Cancer Shot.
Moderna CEO Stéphane Bancel says the biotech's competitive edge stems from its mRNA platform, likening it to software in Big Tech.
6 days ago 247wallst.com
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Broadcom, Conoco Phillips, HubSpot, MercadoLibre, Moderna, Occidental Petroleum, PNC Financial, Trimble, and More
Wall Street analysts are reshuffling their bets across chips, crypto, energy, and beyond as the Fed prepares to deliver its next rate verdict. Find out which stocks got surprise upgrades, which took…
1 week ago fool.com
Which Healthcare ETF Is the Better Buy: Invesco’s Broad RSPH or First Trust’s Biotech FBT?
FBT has outperformed RSPH by a wide margin recently. The question is whether you want to own the fund that won last year or the one built to hold up over many years.
1 week ago investopedia.com
Moderna's Rally May Have Run Out of Steam. Here's What to Watch Next
Moderna's stock has taken a big hit that could signal the end of this year's cancer vaccine-driven rally. It may not be too late to play the forces behind its rise.
1 week ago youtube.com
Data about Merck and Moderna Melanoma Vaccine Leaks Out
Leaked data from Moderna and Merck's highly anticipated melanoma vaccine trial has led to a rare disconnect between doctors, who celebrated the result, and Wall Street, which sold off the stocks.…
-
1 week ago benzinga.com
Piper Sandler Reiterates Overweight on Moderna, Raises Price Target to $230
Piper Sandler analyst Edward Tenthoff reiterates Moderna (NASDAQ:MRNA) with a Overweight and raises the price target from $167 to $230.
1 week ago marketwatch.com
The excitement around Moderna's cancer vaccine is cooling. Here's why.
Investors had “incredibly high” expectations around the Phase 3 data for the drugmaker's experimental cancer treatment.
1 week ago 247wallst.com
Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady
A closely tracked personalized melanoma vaccine met its main goal. Its effect on distant spread came in far smaller than an earlier study suggested in a late-stage trial.
1 week ago benzinga.com
Moderna Stock Saga: Leaked Data, a Panicked Influencer and Perfect Timing
Moderna Inc. (NASDAQ:MRNA) investors spent months treating the company's cancer vaccine as a potential cure. Last week, leaked trial data delivered a reality check.
1 week ago benzinga.com
Moderna Stock Saga: Leaked Data, a Panicked Influencer and Perfect Timing
Moderna’s stock went on a wild ride last week that included a data leak and a dramatic tale from a social media influencer.
1 week ago benzinga.com
MercadoLibre, Banco Bradesco, Itaú Unibanco And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
Brazilian stocks plunged premarket after Lula's reelection, led by XP (-46%), Inter & Co (-34.7%), StoneCo (-33.8%) and MercadoLibre (-14.1%).
1 week ago fool.com
Breakfast News: Science Strikes Back at Cancer
Cancer trial data shines at ESMO 2026, earnings flood after tough market week, and more…
1 week ago benzinga.com
Moderna Stock Slides Again Friday: What's Going On?
Moderna slides in premarket trading post ESMO data leak, despite Phase 3 vaccine trial showing a 42% cut in melanoma recurrence.
1 week ago benzinga.com
Deckers Outdoor Posts Mixed Q2 Results, Joins BayCom, Five Point Holdings And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures fell, led by Deckers down 9% after mixed results and reduced FY27 guidance. BayCom, ROLR, Trulieve and others also slid premarket.
-
1 week ago benzinga.com
Merck And Moderna Report Phase 3 Melanoma Trial Results For Personalized mRNA Cancer Therapy; Intismeran Plus KEYTRUDA Cuts Melanoma Recurrence Or Death Risk By 42%
Intismeran plus KEYTRUDA significantly reduced the risk of recurrence or death by 42% (HR=0.58 [95% CI, 0.45–0.75]; two-sided p<0.001) compared to KEYTRUDA alone for patients with completely resected…
1 week ago benzinga.com
Why Is Moderna Stock Sinking Thursday?
Moderna stock plummeted 25% following an alleged ESMO 2026 abstract leak showing lower-than-expected melanoma vaccine Phase 3 efficacy.
1 week ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Profusa (NASDAQ:PFSA) shares moved upwards by 35.4% to $1.15 during Thursday's regular session. Karyopharm Therapeutics (NASDAQ:KPTI) shares increased by 29.12% to $0.55. The company's market…
1 week ago benzinga.com
FDA Lifts Three-Year Freeze On Arbutus Biopharma's Hepatitis B Study
The FDA lifts its 3-year clinical hold on Arbutus Biopharma's AB-101 hepatitis B drug candidate, clearing US clinical trials.
-
1 week ago benzinga.com
TD Cowen Maintains Hold on Moderna, Raises Price Target to $90
TD Cowen analyst Tyler Van Buren maintains Moderna (NASDAQ:MRNA) with a Hold and raises the price target from $40 to $90.
2 weeks ago benzinga.com
What's Going On With Moderna Stock Monday?
Moderna shares are trading higher Monday ahead of detailed Phase 3 melanoma data due Saturday and after BofA raised its price target.
2 weeks ago benzinga.com
Nasdaq 100 Slides As Micron, SanDisk, CoreWeave Sink: Stock Market Today
The Nasdaq 100 fell 1.5% at midday Friday as memory chips and AI-debt names sold off, while Fed Chair Warsh declined to rule out an October hike after hot CPI and PPI. WTI held near $96, the 10-year…
2 weeks ago benzinga.com
Nike, Moderna, Walmart Get a Lift as Traders Flee AI Stocks
Concerns about tech companies overspending on AI prompted investors to rotate out of the trade and seek value elsewhere.
-
2 weeks ago benzinga.com
Fastenal To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Thursday
Analysts raised targets for TSM, MRNA, ALEC and WMT; cut AZZ, ARRY and ALGN targets, upgrading ARRY/WMT and downgrading ALGN.
-
2 weeks ago benzinga.com
Goldman Sachs Maintains Neutral on Moderna, Raises Price Target to $137
Goldman Sachs analyst Salveen Richter maintains Moderna (NASDAQ:MRNA) with a Neutral and raises the price target from $120 to $137.
2 weeks ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
3 weeks ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
3 weeks ago benzinga.com
Palantir CTO Says Some AI Researchers Are So Sure It Will Cure Cancer They’ve Started 'Smoking' — Warns Both AI Extremes Reflect ‘Social Delusion’
Palantir CTO Shyam Sankar calls AI doomsday predictions theological, while warning that extreme optimism amounts to ‘mass psychosis,'
3 weeks ago benzinga.com
Stephen King Slams Trump’s New Press Secretary as Past Vaccine Conspiracy Theories, Third-Term Posts Spark Fresh Controversy: 'She Appears to Have Tried to…'
Stephen King slammed Trump’s incoming press secretary over her vaccine conspiracy theories and controversial posts.
3 weeks ago benzinga.com
Moderna Stock Hits New 52-Week High: What's Happening?
Moderna shares are rising Friday to a fresh 52-week high. The stock enters the Nasdaq-100 Index. Here's what you should know.
3 weeks ago benzinga.com
A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally
A new NIH-backed initiative to speed up personalized cancer vaccine development sent stocks like MRNA, BNTX, and NVAX surging Friday.
3 weeks ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…